Amphastar Pharmaceuticals: Q2 Earnings Insights

Amphastar Pharmaceuticals (NASDAQ:AMPH) reported its Q2 earnings results on Monday, August 8, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Amphastar Pharmaceuticals beat estimated earnings by 8.33%, reporting an EPS of $0.39 versus an estimate of $0.36.

Revenue was up $21.80 million from the same period last year.

Last quarter the company beat on EPS by $0.11 which was followed by a 7.05% increase in the share price the next day.

Here's a look at Amphastar Pharmaceuticals's past performance:

Quarter	Q1 2022	Q4 2021	Q3 2021	Q2 2021
EPS Estimate	0.36	0.37	0.24	0.21
EPS Actual	0.47	0.42	0.46	0.21
Revenue Estimate	113.33M	111.44M	103.24M	101.78M
Revenue Actual	120.37M	120.89M	112.20M	101.66M

To track all earnings releases for Amphastar Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.